Filing Details

Accession Number:
0001415889-22-002200
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-02 19:58:51
Reporting Period:
2022-02-28
Accepted Time:
2022-03-02 19:58:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1620564 Sive Gesua Daniel Salvadori 100 Abbott Park Road
Abbott Park IL 60064
Executive Vice President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Disposition 2022-02-28 10,551 $122.41 113,798 No 4 F Direct
Common Shares Without Par Value Disposition 2022-03-01 1,550 $118.17 112,248 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct